血小板减少合并缺血性卒中的诊治进展

doi:10.3969/j.issn.1673-5765.2019.02.019

摘要/Abstract

摘要：

在临床中，如果免疫性血小板减少（immune thrombocytopenia，ITP）、肝素诱发的血小板减少（heparin-induced thrombocytopenia，HIT）、血栓性血小板减少性紫癜（thrombotic thrombocytopenic purpura， TTP）等血小板减少疾病患者合并缺血性卒中，其治疗存在矛盾。本文对血小板减少的病因机制及血小板减少合并急性缺血性卒中时静脉溶栓、机械取栓及抗血小板治疗等方面的研究进展进行了综述。

文章导读： 对于血小板减少合并急性缺血性卒中的患者，除了针对血小板减少进行治疗外，卒中急性期的溶栓、抗凝、血管内介入治疗均无明确规范，临床上应根据患者情况进行个体化治疗。

关键词: 血小板减少; 缺血性卒中; 溶栓

Abstract:

There are contradictions in treatment of thrombocytopenia combined with ischemic stroke, such as immune thrombocytopenia (ITP), heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP). This article reviewed that the etiological mechanism of thrombocytopenia, and advance in intravenous thrombolysis, mechanical thrombolysis and antiplatelet therapy in patients with thrombocytopenia and ischemic stroke.

Key words: Thrombocytopenia; Ischemic stroke; Thrombolysis

张爱娟，高琳芝，张爱元. 血小板减少合并缺血性卒中的诊治进展[J]. 中国卒中杂志, 2019, 14(02): 178-182.

ZHANG Ai-Juan,GAO Lin-Zhi, ZHANG Ai-Yuan. Progress in Diagnosis and Treatment of Ischemic Stroke Patients with Thrombocytopenia[J]. Chinese Journal of Stroke, 2019, 14(02): 178-182.

参考文献

[1] ONDER H，ARSAVA E M，ARAT A，et al.

Acute middle cerebral artery occlusion treated by

thrombectomy in a patient with myelodysplastic

syndrome and severe thrombocytopenia[J]. J Vasc

Interv Neurol，2015，8（4）：22-26.

[2] MARTINA M，TIMO V，PETER K，et al. Only

severe thrombocytopenia results in bleeding and

defective thrombus formation in mice[J]. Blood，

2013，121（24）：4938-4947.

[3] ICHIJO M，ISHIBASHI S，OHKUBO T，et

al. Elevated platelet microparticle levels after

acute ischemic stroke with concurrent idiopathic

thrombocytopenic purpura[J]. J Stroke Cerebrovasc

Dis，2014，23（3）：587-589.

[4] PARK H K，LEE S H. Ischemic stroke associated

with immune thrombocytopenia：lesion patterns and

characteristics[J]. Neurol Sci，2014，35（11）：1801-

1806.

[5] KIM H，HWANG S S，UH Y，et al. A case

associated with comorbidities among cerebral

infarction，indiopathic thrombocytopenic purpura，

and triple X syndrome[J]. Turk J Hematol，2014，31

（2）：184-187.

[6] YUNOKI M，SUZUKI K，UNEDA A，et al.

Multiple cerebral infarctions in a patient with

idiopathic thrombocytopenic purpura[J]. Iran J

Neurol，2016，15（3）：177-179.

[7] HAYASHI T，AKIOKA N，KASHIWAZAKI D，et

al. Ischemic stroke in pediatric moyamoya disease

associated with immune thrombocytopenia-a case

report[J]. Childs Nerv Syst，2015，31（6）：991-996.

[8] ZHAO H，LIAN Y，ZHANG H，et al. Ischemic

stroke associated with immune thrombocytopenia[J].

J Thromb Thrombolysis，2015，40（2）：156-160.

[9] LAMBERT M P，GERNSHEIMER T B. Clinical

updates in adults immune thrombocytopenia[J].

Blood，2017，129（21）：2829-2835.

[10] ZHENG X L. ADAMTS13 and von Willebrand

factor in thrombotic thrombocytopenic purpura[J/

OL]. Annu Rev Med，2015，66：211-225. https：//doi. org/10.1146/annurev-med-061813-013241.

[11] SEVY A，DOCHE E，SQUARCIONI C，et al.

Stroke in a young patient treated by alteplase

heralding an acquired thrombotic thrombocytopenic

purpura[J]. J Clin Spheresis，2011，26（3）：152-155.

[12] SALEM M，ELREFAI S，SHRIT M A，et al.

Fondaparinux thromboprophylaxis-associated

heparin-induced thrombocytopenia syndrome

complicated by arterial thrombotic stroke[J].

Thromb Haemost，2010，104（5）：1071-1072.

[13] ITABASHI R，YAZAWA Y，KAWATA K，et al.

Paradoxical brain emboli related to heparin-induced

thrombocytopenia after catheter ablation[J/OL]. J

Stroke Cerebrovas Dis，2015，24（8）：e219-e221.

https：//doi.org/10.1016/j.jstrokecerebrovasd

is.2015.04.021.

[14] KAWANO H，YAMAMOTO H，MIYATA S，et

al. Prospective multicentre cohort study of heparininduced

thrombocytopenia in acute ischaemic stroke

patients[J]. Brit J Haematol，2011，154（3）：378-386.

[15] ROJAS J C，BANERJEE C，SIDDIQUI F，et al.

Pearls & Oy-sters：acute ischemic stroke caused by

atypical thrombotic thrombocytopenic purpura[J/

OL]. Neurology，2013，80：e235-238. https：//doi.

org/10.1212/WNL.0b013e318294b423.

[16] LEE G M，AREPALLY G M. Diagnosis

and management of heparin-induced

thrombocytopenia[J]. Hematol Oncol Clin N Am，

2013，27（3）：541-563.

[17] HUSSEINI N E，MORGENLANDER J C. Pearls

& Oy-sters：Multiple ischemic strokes secondary to

heparin-induced thrombocytopenia[J/OL]. Neurology，

2011，76（11）：e48-e50. https：//doi.org/10.1212/

WNL.0b013e3182104383.

[18] ADAMS C，DHIRENDRA A，AMES P R J.

Ischemic stroke followed by acute thrombocytopenia：

a double iatrogenic whammy[J]. Clin Appl Thromb-

Hem，2011，17（1）：103-105.

[19] AOKI J，IGUCHI Y，KIMURA K，et al. A

pulmonary embolism caused by delayed-onset

heparin-induced thrombocytopenia in a patient with

ischemic stroke[J]. Inter Med，2009，48（11）：921-

924.

[20] CAMARA-LEMARROY C R，INFANTEVALENZUELA

A，ANDRADE-VAZQUEZ C J，et

al. Successful intravenous thrombolysis in a patient

with antiphospholipid syndrome，acute ischemic

stroke and severe thrombocytopenia[J]. Blood

Coagul Fibrin，2016，27（3）：354-356.

[21] FRANK B，GROTTA J C，ALEXANDROV A V，et

al. Thrombolysis in stroke despite contraindications

or warnings?[J]. Stroke，2013，44（3）：727-733.

[22] CRONIN CA，SHAH N，MOROVATI T，et al.

No increased risk of symptomatic intracerebral

hemorrhage after thrombolysis in patients with

European Cooperative Acute Stroke Study（ECASS）

exclusion criteria[J]. Stroke，2012，43（6）：1684-

1686.

[23] European stroke organization（ESO）executive

committee EWC. Guidelines for management of

ischaemic stroke and transient ischaemic attack 2008

[J]. Cerebrovasc Dis，2008，25（5）：457-507.

[24] JAUCH E C，SAVER J L，ADAMS H P JR，et al.

Guidelines for the early management of patients with

acute ischemic stroke：a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J]. Stroke，2013，44

（3）：870-947.

[25] GENSICKE H，AI SULTAN A S，STRBIAN D，et

al. Intravenous thrombolysis and platelet count[J].

Neurology，2018，90（8）：690-697.

[26] SMITH W S，SUNG G，SAVER J，et al. Mechanical

thrombectomy for acute ischemic stroke: final results

of the Multi MERCI trial[J]. Stroke，2008，39（4）：

1205-1212.